The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors

Jason Chia Hsun Hsieh, Guan Yu Chen, David Da Wei Jhou, Wen Chi Chou, Chun Nan Yeh, Tsann Long Hwang, Hung Chi Lin, Hui Chun Chu, Hung Ming Wang, Tzu Chen Yen, Jen Shi Chen*, Min Hsien Wu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Circulating tumor cells (CTC) play important roles in various cancers; however, few studies have assessed their clinical utility in neuroendocrine tumors. This study aimed to prospectively evaluate the prognostic value of CTC counts in Asian patients with neuroendocrine tumors before and during anti-cancer therapy. Patients who were diagnosed with unresectable histological neuroendocrine tumors between September 2011 and September 2017 were enrolled. CTC testing was performed before and during anti-cancer therapy using a negative selection protocol. Chromogranin A levels were also assessed. Univariate and multivariate Cox’s proportional hazard model with forward LR model was performed to investigate the impact of independent factors on overall survival and progression-free survival. Kaplan–Meier method with log-rank tests were used to determine the difference among different clinicopathological signatures and CTC cutoff. The baseline CTC detection rate was 94.3% (33/35). CTC counts were associated with cancer stages (I-III vs. IV, P = 0.015), liver metastasis (P = 0.026), and neuroendocrine tumor grading (P = 0.03). The median progression-free survival and overall survivals were 12.3 and 30.4 months, respectively. In multivariate Cox regression model, neuroendocrine tumors grading and baseline CTC counts were both independent prognostic factors for progression-free survival (PFS, P = 0.005 and 0.015, respectively) and overall survival (OS, P = 0.018 and 0.023, respectively). In Kaplan-Meier analysis, lower baseline chromogranin A levels were associated with longer PFS (P = 0.024). Baseline CTC counts are associated with the clinicopathologic features of neuroendocrine tumors and are an independent prognostic factor for this malignancy.

Original languageEnglish
Article number19917
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - 27 Dec 2019

Fingerprint Dive into the research topics of 'The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors'. Together they form a unique fingerprint.

Cite this